Evidence map›Paper›PMID 41741649›Full record

ArticleNature2026

Human hippocampal neurogenesis in adulthood, ageing and Alzheimer's disease.

Ahmed Disouky, Mark A Sanborn, K R Sabitha, Mostafa M Mostafa, Ivan Alejandro Ayala, David A Bennett, Yisha Lu, Yi Zhou, C Dirk Keene, Sandra Weintraub and 6 more

Abstract read
In one paragraph

Article in Nature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Ras-MAPK somatic variants in mesial temporal lobe epilepsy.Current opinion in genetics & development · 2026
    Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Temporal Interference Stimulation Enhances Neural Regeneration.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  12. Isolation of postnatal human neural stem cells.bioRxiv : the preprint server for biology · 2026
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Ahmed DisoukyDepartment of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, IL, USA.
Mark A SanbornDepartment of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-5308-4680
K R SabithaDepartment of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0002-1679-6694
Mostafa M MostafaDepartment of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, IL, USA.
Ivan Alejandro AyalaMesulam Center for Cognitive Neurology and Alzheimer's disease, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
David A BennettRush Alzheimer's Disease Center, Chicago, IL, USA.
Yisha LuInstitute of Neuroscience, State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.
Yi ZhouInstitute of Neuroscience, State Key Laboratory of Neuroscience, CAS Center for Excellence in Brain Science and Intelligence Technology, Chinese Academy of Sciences, Shanghai, China.ORCID http://orcid.org/0000-0001-6500-8554
C Dirk KeeneUW Biorepository and Integrated Neuropathology (BRaIN) Lab, Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA.ORCID http://orcid.org/0000-0002-5291-1469
Sandra WeintraubMesulam Center for Cognitive Neurology and Alzheimer's disease, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Tamar GefenMesulam Center for Cognitive Neurology and Alzheimer's disease, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
M-Marsel MesulamMesulam Center for Cognitive Neurology and Alzheimer's disease, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Changiz GeulaMesulam Center for Cognitive Neurology and Alzheimer's disease, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA.
Mark Maienschein-ClineResearch Informatics Core, University of Illinois Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-6619-6788
Jalees RehmanDepartment of Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL, USA. jalees@uic.edu.ORCID http://orcid.org/0000-0002-2787-9292
Orly LazarovDepartment of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, IL, USA. olazarov@uic.edu.ORCID http://orcid.org/0000-0002-5887-948X

Funding

Research Education Core FP30AG072977 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Darby Morhardt · 2021 to 2026
$26.3M
The role of PS1 in regulation of adult neurogenesis in the intact and Alzheimer?sR01AG033570 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Orly Lazarov · 2009 to 2026
$5.6M
Hippocampal neurogenesis in cognitive function and dysfunction in Alzheimer's disease.R01AG076940 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Orly Lazarov · 2022 to 2026
$3.7M
High-Throughput 3D Multiscale Mass Spectrometry Imaging for Understanding Neurochemical Heterogeneity in Alzheimer's DiseaseR01AG078797 · NIA · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI Fan Lam, Orly Lazarov · 2022 to 2026
$3.6M
Plasticity circuits in Alzheimer s diseaseRF1AG033570 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LAZAROV, ORLY · 2020 to 2021
$2.9M
Mechanisms underlying sporadic Alzheimer's diseaseR01AG060238 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LAZAROV, ORLY · 2018 to 2022
$2.4M
Training program in the biology and translational research on Alzheimer's diseaseand related dementiasT32AG057468 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Stephanie M Cologna, Orly Lazarov · 2017 to 2026
$2.3M
Acceleration of AD Phenotypes in Asymptomatic Mouse ModelsR01AG062251 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LAZAROV, ORLY · 2018 to 2022
$2.2M
Training Program in Personalized Cardiovascular Medicine (TPIPCVM)T32HL139439 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI DARBAR, DAWOOD · 2018 to 2022
$2.1M
The role of APP in neurogenesis and AD in Down syndromeRF1AG079002 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LAZAROV, ORLY · 2022 to 2022
$2.0M
Pathogen-induced cellular senescence and blood-brain barrier dysfunction in Alzheimer's DiseaseR01AG091545 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Jalees Rehman · 2025 to 2026
$1.6M
The role of APP in neurogenesis and AD in Down syndromeR01AG079002 · NIA · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Orly Lazarov · 2025 to 2026
$1.3M
NHLBI NIH HHS T32 HL139439NIA NIH HHS F31 AG090005NIA NIH HHS P30 AG072977NIA NIH HHS R01 AG033570NIA NIH HHS R01 AG060238NIA NIH HHS R01 AG062251NIA NIH HHS R01 AG076940NIA NIH HHS R01 AG078797NIA NIH HHS R01 AG079002NIA NIH HHS R01 AG091545NIA NIH HHS R21 AG061628NIA NIH HHS RF1 AG033570NIA NIH HHS RF1 AG079002NIA NIH HHS T32 AG057468
6 · The paper itself

Abstract

The existence of human hippocampal neurogenesis has long been disputed

Indexed as

AgingAlzheimer DiseaseHippocampusNeurogenesisAdultAgedAged, 80 and overAstrocytesCA1 Region, HippocampalChromatinCognitionFemaleHumansMaleMemoryMiddle AgedChromatinTranscription Factors

Identifiers

PMID41741649
PMCPMC13048220

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.